Region
CDMOs in North Africa
Compare North African CDMOs across Egypt, Morocco, Tunisia, and Algeria. Filter by manufacturing type, regulatory approvals, and regional market access.
13 companies listed
North African CDMO Manufacturing
North Africa's pharmaceutical manufacturing is led by Egypt (largest market, 100+ manufacturing facilities) and Morocco (growing export hub targeting Francophone Africa). The region offers cost-competitive manufacturing with strategic access to both Middle Eastern and sub-Saharan African markets. Regulatory frameworks are improving, with some countries aligning toward WHO prequalification standards.
Egypt is the largest pharmaceutical producer on the African continent, with a domestic market exceeding $6 billion. Egyptian CDMOs primarily produce generics and branded generics in oral solid dose and injectable formats. The Egyptian Drug Authority (EDA) has modernized its GMP inspection framework, and several Egyptian facilities have achieved WHO prequalification.
Morocco is positioning itself as a pharmaceutical export hub, leveraging free trade agreements with the EU, US, and African countries. The country's pharmaceutical manufacturing zone near Casablanca offers modern infrastructure and government incentives for pharma companies targeting African markets.
Companies (13)
Afric Phar
Morocco
Afric-Phar is a Moroccan pharmaceutical company offering contract manufacturing services with a complete value chain including regulatory affairs, quality assurance, quality control, production, logistics, and promotion. The company operates from a 1,300 m2 industrial site and provides global contract services for pharmaceutical partners entering the North African market.
Small Molecule Drug ProductOral Solid DoseFormulation Development
BioGeneric Pharma (BGP)
Egypt
BioGeneric Pharma S.A.E (BGP) is an Egyptian international biopharmaceutical company specializing in the development, production, analysis, and marketing of therapeutic recombinant proteins, biosimilars, and vaccines. BGP operates a state-of-the-art biomanufacturing facility in 10th of Ramadan Industrial City, Egypt. The company offers contract manufacturing (CMO) and toll manufacturing services with capabilities spanning biomanufacturing, fill/finish (vials, PFS, cartridges), quality control labs, and mRNA technology (WHO mRNA technology transfer hub partner). Has single-use technology for upstream (25L to 2,000L bioreactors) and downstream processing.
Frequently Asked Questions
What types of pharmaceutical manufacturing are available in North Africa?+
North African CDMOs primarily offer: oral solid dosage manufacturing (tablets, capsules), sterile injectable production (vials, ampoules), liquid and semi-solid formulations, and packaging for regional distribution. Advanced biologics manufacturing is limited but developing. Egypt's VACSERA has vaccine production capabilities. The region is strongest for generic drug product finishing and regional supply chain management.
How do North African CDMOs support access to African markets?+
North African CDMOs provide a gateway to sub-Saharan African markets through: WHO prequalification (enabling participation in donor-funded procurement programs), regulatory harmonization via the African Medicines Agency (AMA) initiative, established distribution networks across Francophone and Anglophone Africa, cost-competitive manufacturing versus Western alternatives, and local regulatory expertise for national submissions.
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
